Chapter 82: Drugs for Peptic Ulcer Disease

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, I feel like we usually think of the stomach as this indestructible iron tank.

Right, yeah, because it kind of has to be.

Exactly.

I mean, it's a muscular sac, literally filled with hydrochloric acid that is like strong enough to dissolve a razor blade.

It is a genuinely hostile environment.

It needs to break down all the proteins we eat and basically obliterate the incoming pathogens we swallow every single day.

Right, but okay, that brings up the obvious question.

If it can dissolve metal, why doesn't the stomach just dissolve itself?

Right.

It honestly seems like a biological miracle that we don't all just have, you know, constant gaping holes in our digestive tracts.

Yeah, it feels miraculous until you really look under the hood at the pharmacology and the physiology.

We tend to want the human body to be this straightforward static thing, but the gastrointestinal system is actually this highly dynamic, really delicate balancing act.

And when that balance fails, your patient ends up with some serious painful damage.

Which is precisely why we're here today.

We are taking a deep dive into chapter 82.

That's

Ulcer Disease, or PUD, from Lynn's Pharmacology for Nursing Care.

Such a crucial chapter.

It really is.

And we designed this specifically for you, the nursing student who is gearing up for a major pharmacology exam or getting ready to step onto the clinical floor.

And we're going to break it all down.

Exactly.

We're going to look at exactly how we use medications to tip the scales back in the stomach's favor, basically translating all that dense drug information into the actual real clinical reasoning you need at the bedside.

And, you know, to really understand the drugs, you have to understand that balance first.

The textbook canes a great picture of this.

Figure 82 .1.

Oh, yeah, the literal scale.

Right.

It shows a little scale.

On one side, you have the defensive factors.

This is the stomach's armor, essentially.

It's made up of mucus, bicarbonate, blood flow, and prostaglandins.

So the mucus part makes total sense to me.

I mean, it's a physical barrier.

But why are flow and prostaglandins on that defensive list?

Well, blood flow is actually one of the most critical components.

Think about it.

If a patient loses adequate blood flow to the gastric mucosa, it causes local ischemia.

Oh, right.

So the tissue is dying.

Exactly.

The cells get starved of oxygen and they instantly become vulnerable to the acid.

And then, you know, prostaglandins are really the unsung heroes of the gut.

How so?

They stimulate the production of that mucus.

They stimulate the release of bicarbonate, which neutralizes any acid that actually sneaks through the mucus layer.

And they promote the vasodilation that keeps that blood flowing.

They even actively suppress gastric acid secretion.

OK, so that's our armor.

But then on the other side of the scale, pulling it down, you have the aggressive factors.

So that's helicobacter pylori, NSAIDs, gastric acid, pepsin, and smoking.

Heavy hitters, yeah.

Right.

And the textbook calls H.

pylori and NSAIDs the big two culprits.

But there is one absolute rule here that the chapter just really hammers home.

Without acid, no ulcer will form.

That is the fundamental truth of peptic ulcer disease.

Like acid is an absolute requirement for an ulcer to develop.

Period.

Period.

It injures the cells directly, sure, but it also indirectly activates pepsin.

And pepsin is an enzyme, right?

Yeah, it's a proteolytic enzyme, meaning it literally breaks down protein.

So not only is the acid burning the tissue, the pepsin is actually digesting the gut wall.

That is horrifying.

It's bad.

But even if a patient is heavily infected with H.

pylori or they take a massive amount of NSAIDs, the ulcer just won't form if gastric acid isn't present to do that initial eroding.

So if we know acid is the trigger, and H.

pylori or NSAIDs are usually the underlying cause, how does that shape our actual goals of therapy?

Well, the text outlines four main goals.

You want to alleviate symptoms, promote healing, prevent complications like a massive hemorrhage, and prevent recurrence.

But looking at the huge list of drugs we have in this chapter, only one class actually alters the disease process itself.

Yes.

And that is a vital distinction for nursing exams.

Only antibiotics can eradicate H.

pylori and actually cure the ulcer.

So all the other stuff?

Everything else.

The acid blockers, the physical protectants, they don't cure anything.

They simply create this low acid environment that's conducive to the body healing itself.

Got it.

If you just give an acid blocker to a patient with an H.

pylori ulcer, and you skip the antibiotics,

the relapse rate is incredibly high the minute they stop taking the acid blocker.

Okay, before we get into those antibiotics, I do want to look at the non -drug therapies, because there's this huge myth we need to clear up.

The traditional ulcer diet.

Oh boy, yeah.

For decades, people thought drinking milk and eating bland food was like the medical answer to an ulcer.

Which is wild, because diet actually plays a very minor role in ulcer healing.

It's like trying to fix a bursting pipe by just slapping a wet paper towel on it.

It doesn't address the pressure or the leak at all.

Exactly.

It's completely ineffective for healing.

The actual clinical teaching point for you as a nurse isn't about telling the patient what to eat, but how to eat.

Right.

You need to teach them to consume five or six small meals a day rather than three large ones.

Because smaller meals prevent those massive sudden fluctuations in stomach pH.

Spot on.

It keeps the acid levels relatively stable.

And of course, the other non -drug measures are totally non -negotiable.

Smoking and NSAIDs.

Right.

They have to stop smoking, which actively delays healing, and they need to stop taking ulcerogenic NSAIDs if at all possible.

All right.

So let's say a patient comes in, they've got the symptoms, and we suspect H.

pylori is the aggressive factor causing this imbalance.

We obviously have to test for it before dropping the antibiotic bombs.

The text mentions invasive tests where you go in with an endoscope and actually biopsy the tissue, but the non -invasive tests seem way more common.

They are.

And the breast test is actually a really elegant piece of diagnostics.

How does that work?

So the patient ingests urea that has been radio labeled.

H.

pylori naturally produces this enzyme that converts urea into carbon dioxide and ammonia.

So if the bacteria are present in the stomach, they convert that radio labeled urea, the carbon dioxide gets absorbed into the blood,

exhaled through the lungs, and then we can measure it in the patient's breath.

That is so crazy.

It's fast and it's highly accurate.

We also have stool tests to look for bacterial antigens and blood tests to look for antibodies, but the breath test is great.

Okay.

So the test confirms the bug is there and now we have to wipe it out.

The textbook lists five main antibacterial drugs.

And what struck me is that they all have these highly specific, almost weird nursing considerations.

They really do.

You have to pay attention to the details with these.

Take amoxicillin, for instance.

It's a cell wall disruptor.

We use it for ear infections, strep throat, whatever.

But the book says its antibacterial activity is highest at a neutral pH.

That seems completely backwards if we are trying to kill a bacteria living in stomach acid.

It does seem super counterintuitive.

Amoxicillin is highly sensitive to acid.

It essentially gets destroyed before it can work if the pH is too low.

So what do we do?

Which is precisely why we never give it alone for PUD.

We almost always pair amoxicillin with an anti -secretory agent, like a proton pump inhibitor.

Oh, so we force the stomach's pH to rise.

Exactly.

We raise it to a neutral level, which gives the amoxicillin the environment it needs to actually be lethal to the H.

pylori.

That makes a lot of sense.

Then there's clarithromycin, which inhibits bacterial protein synthesis.

Used to be like the gold standard, but the text gives a pretty stark warning about it now.

The clinical heads up there is that resistance is rising incredibly fast.

In some areas, resistance to clarithromycin actually exceeds 20%.

So it's really losing its efficacy.

And then we have bismuth, like the classic pink liquid from the pharmacy.

The text says it acts topically to disrupt the cell wall of the bacteria.

But the patient teaching point here is massive, and it's all about a very alarming side effect.

You have to warn your patients about the color changes.

Right.

Bismuth reacts with sulfur in the saliva and the gastrointestinal tract to form bismuth sulfide.

Bismuth sulfide is completely harmless, but it is pitch black.

Oh, wow.

It will turn the patient's tongue black, and it will turn their stool black.

I can only imagine a patient who already has a bleeding ulcer looking into the toilet seeing pitch black stool, which is, you know, a classic sign of an upper GI bleed, and absolutely panicking.

They will end up in the emergency room in full panic mode if you don't provide that anticipatory guidance.

You have to tell them it's just an expected harmless chemical reaction from the drug.

Good to know.

What about tetracycline?

I know it's another protein synthesis inhibitor and resistance is rare, but there's a strict contraindication here.

Yeah, tetracycline has this really strong affinity for calcium.

If it's given to a pregnant patient or a young child, the drug will actually bind to the calcium in the developing tooth enamel,

and it causes this permanent, irreversible yellow or brown staining of the teeth.

That's awful.

So it is strictly contraindicated in pregnant patients and children under eight years old.

Got it.

And finally, we have metronidazole, and the nursing teaching here is totally unforgiving when it comes to a patient's lifestyle.

Absolute avoidance of alcohol.

Like zero alcohol.

Absolute zero.

If a patient drinks even a small amount of alcohol while on metronidazole, they will experience a severe disulfam -like reaction.

What does that look like?

We're talking extreme nausea, violent vomiting, flushing, palpitations.

It is a miserable, potentially dangerous experience.

So looking at all these drugs, the American College of Gastroenterology guidelines basically require a combination pack.

You're giving two to three of these antibiotics plus an acid reducer like a PPI all at the same time.

Yeah, it's intense.

Let me play devil's advocate for a second.

We're asking a patient whose stomach already hurts to swallow up to a dozen pills a day for two weeks.

Isn't compliance going to be an absolute nightmare?

It is a massive hurdle.

The regimens are really complex, they are expensive, and they are so tough on the GI tract.

Nausea and diarrhea are very common side effects of essentially nuking your gut flora.

So how do you, as the nurse, convince them to stick with it?

You have to explain the underlying strategy.

We use multiple antibiotics simultaneously because if we only use one, the H.

pylori will rapidly mutate and develop resistance.

Right.

We have to hit the bacteria from multiple angles at once to eradicate it.

And you have to frame it as a cure versus chronic management.

A 14 -day course of a dozen pills is miserable, yes.

But it cures the disease that is infinitely safer and cheaper than treating recurrent, life -threatening, bleeding ulcers for the next 30 years.

I really like that framing.

Cure the root cause, don't just manage the symptom.

Okay, so if we've dropped the bombs and cleared out the bacteria, we still have this raw exposed tissue in the stomach.

Right, the ulcer is still there.

How do we stop the acid from eating away at it while it heals?

That brings us to the H2 receptor antagonists.

The textbook highlights cementadine as the prototype.

It was actually the world's first blockbuster drug in the 70s.

How exactly is it turning off the acid?

To understand cementadine, we have to look closely at the parietal cells in the stomach wall.

The acid factories.

Exactly.

These are the literal factories that manufacture gastric acid.

Now histamine in the body acts through two main types of receptors.

H1 receptors are the ones involved in like allergic reactions.

Like what you take Benadryl for.

Right.

But H2 receptors are located right on those parietal cells.

When histamine binds to an H2 receptor, it signals the cell to secrete gastric acid.

Cementadine selectively blocks those H2 receptors.

So it basically cuts off the signal telling the factory to produce.

Exactly.

It significantly reduces both the volume of gastric juice produced and its concentration of hydrogen ions.

Which makes it great for PUD and over -the -counter heartburn relief.

The book also mentions it's used for Zollinger -Ellison syndrome.

Yeah, Zollinger -Ellison syndrome is a rare condition where a tumor secretes a hormone called gastrin and that causes massive relentless hypersecretion of gastric acid.

H2 blockers can help manage it, but because the acid production is so extreme, they usually require very high doses.

Let's get into the adverse effects of cementadine because understanding the why here seems like prime exam material for nursing students.

First, it has antiandrogenic effects.

What does an ulcer drug have to do with hormones?

It's an unintended consequence of the drug's molecular structure.

Cementadine actually binds to androgen receptors in the body, creating a blockade.

Oh, wow.

In male patients, this can cause gynecomastia, which is enlarged breast tissue, as well as reduced libido and impotence.

That sounds incredibly distressing for a patient.

It is, but the reassuring teaching point for the nurse to provide is that these effects are entirely reversible.

They resolve when the medication is stopped.

Okay, good.

The book also lists CNS effects, like confusion, hallucinations, and even lethargy.

But it notes we mainly see this in older adults.

Why are older patients specifically at risk for the psychiatric side effects?

If we connect this back to pharmacokinetics, cementadine is eliminated by the kidneys and metabolized by the liver.

Okay.

As we age, renal and hepatic function naturally decline.

Because an older adult can't clear the drug from their system as efficiently, the levels build up in the bloodstream.

And then it crosses over.

Eventually, the concentration gets high enough to cross the blood -brain barrier, triggering those central nervous system side effects.

It's a perfect example of why we adjust doses for older populations.

And then there's the risk of pneumonia.

I really struggle to connect these dots.

Why would blocking stomach acid increase your risk of a lung infection?

It's an ecological shift in the body.

Gastric acid is highly lethal.

It normally kills most of the bacteria we swallow.

Right.

When you drastically reduce that acid with an H2 blocker, the stomach becomes a much more hospitable environment.

Bacteria survive and begin to colonize the stomach.

Oh, I see where this is going.

Yeah.

Some of those bacteria can eventually migrate up the esophagus, enter the respiratory tract, and cause pneumonia.

Wow.

That is wild.

And we have to talk about drug interactions because cementadine is notorious for this.

It is a vital nursing implication.

Cementadine inhibits hepatic drug metabolizing enzymes, specifically the cytochrome P450 system.

Okay.

This means it essentially stops the liver from breaking down other medications.

Causing their levels to rise dangerously high in the blood.

So if a patient is on a drug with a narrow therapeutic window, this could be disastrous.

Exactly.

You have to be incredibly careful if the patient is taking warfarin, phenytoin, or theophylline.

The cementadine will cause those drugs to build up to toxic levels.

Are there any administration timing rules?

Yes.

Quick note on that.

If the patient is taking antacids to manage their pain,

they must be given at least one hour apart from cementadine.

Otherwise, the antacid will block the absorption of the cementadine.

Okay.

So if an H2 blocker like cementadine turns down the thermostat on the acid factory by blocking the histamine signal,

our next class of drugs, the proton pump inhibitors or PPIs, seems to bypass the signals entirely and just cut the power line to the factory.

That is a perfect way to visualize it.

The prototype PPI is omeprosyl.

Okay.

Inside that parietal cell, the final step of acid production relies on an enzyme called H plus HAK plus ATPase.

This is the literal proton pump.

It doesn't matter what signal the cell receives, histamine, gastrin, whatever.

This pump is the final common pathway that pushes the acid out into the stomach.

Omeprosyl causes irreversible inhibition of this specific pump.

Wait, irreversible?

But the text says its half -life is only about one hour in the body.

How can it be irreversible if it's gone in an hour?

The drug itself is cleared quickly, yes.

Right.

But while it's in the system, it covalently binds to the enzyme, permanently breaking it.

Oh, wow.

So even after the omeprosyl has been excreted, the acid blocking effect lasts for days.

The stomach can only resume acid production when the body physically manufactures entirely new proton pump enzymes to replace the broken ones.

That's why a single dose can reduce acid production by 97 % within two hours.

Exactly.

It's incredibly powerful.

Now, from a nursing administration's standpoint, omeprosyl capsules contain enteric -coated granules.

Why this special packaging?

Because omeprosyl is acid label.

If it were just exposed in the stomach, the very acid it's trying to stop would destroy the drug before it could work.

The enteric coating ensures that granules survive the harsh stomach environment.

They only dissolve once they reach the more alkaline environment of the duodenum, where they can be safely absorbed into the bloodstream and carried to the parietal cells.

So do not crush them.

The absolute rule for patient teaching here is, never crush or chew these capsules.

You'll destroy the coating.

The chapter also has a special interest box on GERD gastroesophageal reflux disease.

It talks about erosive versus non -erosive GRD.

Right.

While H2 blockers are often used for mild GRD, PPIs are the undisputed drugs of choice for severe cases.

Makes sense given how strong they are.

They're vastly superior at healing erosive esophagitis, where the acid has actually damaged the lining of the esophagus and maintaining long -term remission.

But shutting down acid production that profoundly isn't without risks?

There are some serious safety alerts tied to PPIs.

First, there's a dose -related risk for C.

difficile infection.

It goes back to that ecological shift we talked about with pneumonia but in the gut.

By profoundly suppressing acid, you alter the normal gut flora.

This creates an environment where C.

diff,

a severe toxin -producing bacteria, can thrive and overgrow.

If a patient on a PTI reports severe diarrhea, it cannot be ignored.

It must be investigated immediately for C.

diff.

There are also long -term risks if a patient stays on a PPI for years.

Fractures and hypomagnesemia?

Why does blocking acid affect our bones and minerals?

Because the absorption of calcium and magnesium in the gut requires an acidic environment.

If you suppress acid for years, the body can't absorb those minerals efficiently.

Oh, I see.

This can lead to osteoporosis and bone fractures, particularly in older adults.

It also leads to dangerously low magnesium levels, which can cause muscle tremors or even fatal cardiac dysrhythmias.

So when it's time to take a patient off a PPI, I'm guessing we don't just stop cold turkey.

Never.

You have to taper them off slowly.

If you stop abruptly, the patient experiences acid rebound.

What's that?

The stomach essentially tries to overcompensate for being shut down for so long and pumps out massive amounts of acid.

Patients might actually need a temporary H2 blocker or an antacid during the transition just to manage the rebound dyspepsia.

Let's unpack a really complex clinical scenario from the text.

The clopidogrel dilemma.

Clopidogrel is an antiplatelet drug.

It prevents blood clots in patients who have had stents or heart attacks.

Very common drug.

Right.

But a major side effect of clopidogrel is dangerous GI bleeding.

So logically, a nurse might think, let's put them on omeprazole to protect their stomach from bleeding.

But the text says this is a huge problem.

Why?

The problem happens in the liver.

Clopidogrel is a pro drug.

That means when you swallow it, it's inactive.

It relies on a very specific liver enzyme, CYP2C19, to convert it into its active quat blocking form.

Okay.

Well, omeprazole and other PPIs actually inhibit that exact same CYP2C19 enzyme.

Oh, I see.

So the PPI is protecting the stomach, but it's stopping the liver from activating the antiplatelet drug, meaning the patient is suddenly at risk for a massive clot, a stroke, or a heart attack.

Exactly.

It's an incredibly high stakes balancing act.

You have to choose between the risk of a fatal hemorrhage and the risk of a fatal clot.

How do you choose?

The clinical guidelines give us a decision tool.

You only combine them if the patient has strict risk factors for a GI bleed -like advanced age or a history of ulcers.

Okay.

In that case, preventing a fatal stomach bleed outweighs the slight reduction in the antiplatelet effect.

Yes.

If they do not have risk factors for a GI bleed, you do not combine them.

That is exactly the kind of clinical reasoning that saves lives.

Okay.

Let's look at a totally different strategy.

What if instead of stopping the acid, we just throw a shield over the ulcer so it can heal?

That brings us to sucrophate.

I like to think of this one as a liquid band -aid.

It essentially is.

Sucrophate is a complex substance, but what's fascinating is how it reacts to acid.

What does it do?

When it enters a mildly acidic environment, specifically when the pH is under 4, it undergoes a chemical reaction where it polymerizes.

It physically cross -links into this highly viscous sticky gel.

And that just coats it.

Exactly.

That gel adheres tightly to the ulcer crater, creating a physical barrier against acid and pexin that lasts for up to six hours.

And because it's just a physical barrier sitting in the stomach, it doesn't get absorbed into the bloodstream, right?

So systemic side effects must be super low.

Almost nonexistent.

The main side effect is simply constipation.

However, there is a major nursing implication here.

Which is?

Because sucrophate creates this thick, sticky sludge in the stomach, it can trap other oral medications and prevent them from being absorbed.

You must administer sucrophate at least two hours apart from narrow therapeutic drugs like phenytoin or warfarin.

Okay, another protectant is misoprostol.

We talked earlier about how endocides cause ulcers by wiping out the body's natural prostaglandins.

Misoprostol is a synthetic prostaglandin, so we are just directly replacing what the endocides destroyed to maintain blood flow and mucus production.

But there is a massive bold print safety alert attached to this drug.

It is arguably the most critical safety warning in the entire chapter.

Misoprostol is strictly absolutely contraindicated during pregnancy.

Why?

What does a synthetic stomach protectant do to a pregnancy?

Prostaglandins do more than just protect the stomach.

They also stimulate uterine contractions.

Oh no.

If misoprostol is given to a pregnant patient, it will trigger intense contractions that can cause partial or complete expulsion of the developing fetus.

The risk is absolute.

So if a woman of childbearing age absolutely needs this drug to protect her stomach from chronic NSAI use, what are the nursing protocols?

The requirements are incredibly strict.

She must have a negative serum pregnancy test within two weeks before starting therapy.

Okay.

She must begin the therapy only on the second or third day of her next normal menstrual cycle to guarantee she isn't pregnant.

Wow.

They don't mess around.

No.

She must be given oral and written warnings about the risks and she must be willing to comply with strict, reliable birth control measures while on the drug.

That is intense but obviously necessary.

Let's briefly touch on the chemical neutralizers, antacids.

How are these different from the acid blockers like simetidine or omeprazole?

Antacids don't stop the production of acid.

They are alkaline compounds that directly react with the existing acid already in the stomach to produce neutral salts.

So they don't coat it like sucral fate.

No.

And unlike sucral fate, they do not coat the ulcer.

They simply raise the pH of the entire gastric environment.

Now, balancing the side effects of antacids is practically an art form for patients.

The two major groups we see over the counter are aluminum compounds and magnesium compounds, and they have very opposite effects on the bowel.

You do.

Aluminum -based antacids cause significant constipation.

Magnesium -based antacids cause significant diarrhea.

So one stops you up and one makes you go.

Basically, yeah.

So as a nurse, you teach patients to balance combinations of these two.

In fact, many commercial over -the -counter liquids combine aluminum and magnesium specifically so the side effects cancel each other out, helping the patient maintain normal bowel function.

Are there any hidden dangers with over -the -counter antacids?

The biggest one to watch for is sodium loading.

Some antacid preparations contain very high amounts of sodium.

If you have a patient with heart failure or hypertension,

a high sodium antacid can easily cause systemic fluid retention and severely exacerbate their cardiac condition.

You have to teach them to read the labels carefully.

Excellent point.

All right.

We've navigated the acid factory, defeated the bacteria, and balanced the scales of tepnic ulcer disease.

To wrap up, I want to leave you with one final provocative thought from the clinical evaluation section of this chapter.

It's a profound takeaway for anyone entering clinical practice.

Evaluating the healing of an ulcer is not straightforward because the pain often stops long before the ulcer is actually healed.

Just think about that for a second.

Your patient might say, I feel great.

The pain is gone.

I'm going to stop taking these 12 pills a day.

But if you were to look inside with an endoscope, that raw physical erosion might still be there.

It's a powerful reminder that in nursing, the absence of a symptom doesn't always mean the underlying pathology is cured.

You always have to look deeper, educate your patients on the why, and trust the full course of treatment over a temporary feeling of relief.

A vital lesson for any clinical setting.

Don't let the lack of pain trick you into stopping treatment early.

Absolutely.

Well, that is our deep dive on Chapter 82.

We want to extend a warm, encouraging thank you from all of us here at the Last Minute Lecture Team.

We hope this translated the dense pharmacology into something real, memorable, and applicable for you.

Best of luck on your upcoming exams.

And have a great shift out there on the floor.

Keep making a difference.

β“˜ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Peptic ulcer disease results from an imbalance between protective mechanisms and damaging factors within the gastrointestinal tract, leading to mucosal erosion that can progress to serious complications such as hemorrhage and perforation. The defensive capacity of the stomach and duodenum depends on multiple factors including mucus production, bicarbonate secretion, adequate blood perfusion, and prostaglandin-mediated cytoprotection, while aggressive elements such as Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, gastric acid, and pepsin work to compromise mucosal integrity. Treatment strategies vary based on etiology: Helicobacter pylori-associated disease requires combination antibiotic therapy with at least two or three agents paired with acid suppression to prevent bacterial resistance, whereas nonsteroidal anti-inflammatory drug-induced ulcers necessitate discontinuation of the offending agent and initiation of acid-suppressive therapy, preferably with proton pump inhibitors. Histamine receptor antagonists block acid secretion at the parietal cell level but are increasingly replaced by proton pump inhibitors, which irreversibly inhibit the H+,K+-ATPase enzyme and provide superior acid suppression; however, prolonged use carries risks including fracture, pneumonia, hypomagnesemia, and Clostridioides difficile infection. Mucosal protective agents such as sucralfate and prostaglandin analogs like misoprostol offer alternative mechanisms by creating physical barriers or enhancing mucosal defenses, while antacids provide symptomatic relief through acid neutralization. Nursing considerations encompass proper medication administration techniques, awareness of drug interactions and adverse effects, counseling regarding lifestyle modifications including smoking cessation and avoidance of ulcerogenic substances, and management of rebound acid hypersecretion when discontinuing therapy. The most effective treatment approach combines pharmacological intervention with dietary modifications and elimination of harmful practices to promote mucosal healing and prevent recurrence.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML β™₯